CBC Documentary on “Safer Supply” Program Sparks Controversy Over Balance and Evidence

The CBC’s Fifth Estate released a 43-minute documentary last week examining Canada’s controversial “safer supply” drug policy, prompting criticism over its journalistic approach and apparent advocacy position.

The program, titled “The political war on safe drugs,” focuses on the now-defunded initiative that provided pharmaceutical-grade drugs to people with addictions as an alternative to potentially more dangerous street drugs. While originally centered on hydromorphone prescriptions, some programs had expanded to include fentanyl and other potent substances before federal funding was cut earlier this year.

According to critics, the documentary presents a one-sided view of the policy debate by exclusively featuring addicts, activists, and harm reduction advocates—many of whom helped design the safer supply programs—while excluding opposing expert voices.

“Safer supply” was discontinued after investigations revealed significant medication diversion, with patients reportedly reselling their prescribed hydromorphone to purchase illicit fentanyl. This diversion allegedly contributed to increased opioid circulation in communities, potentially creating new addictions and benefiting organized crime networks.

Several addiction specialists have raised concerns about the program over the past two years. Dozens of physicians, including leaders in addiction medicine, published open letters urging reform or abolition of safer supply initiatives. None of these experts appeared in the documentary, nor did anyone who claimed harm from diverted medications.

B.C. Independent MLA Elenore Sturko, a prominent critic of safer supply, stated that while CBC contacted her for background information, they declined her request to be interviewed for the documentary.

The film has also drawn criticism for its handling of the diversion issue. Critics note that many harm reduction advocates initially dismissed reports of widespread medication diversion as misinformation, only to later claim they had always known hydromorphone would be diverted because it was too weak for fentanyl users.

In one notable segment, safer supply prescriber Dr. Christy Sutherland recounts discontinuing hydromorphone prescriptions after discovering at least 40 percent of her patients were reselling the medication. This led to threats against her life, forcing her to temporarily leave Vancouver. Critics question why the documentary didn’t explore why such information wasn’t more widely shared when government officials were denying diversion problems.

The documentary’s presentation of safer supply as an evidence-based, expert-supported policy has also drawn scrutiny. British Columbia’s top health official acknowledged earlier this year that safer supply is not “fully evidence-based,” while the Canadian Research Initiative in Substance Matters has described the supporting evidence as “essentially low-level.” Many studies supporting the approach have been criticized for methodological weaknesses, including reliance on subjective patient testimony and uncontrolled variables.

The documentary and its accompanying article emphasize that the cancellation of safer supply was politically motivated, particularly by Conservative opposition, while giving minimal attention to the documented problems that led to the program’s defunding.

When questioned about the documentary’s balance and inclusion of critical perspectives, a CBC spokesperson defended the piece, stating it “adheres to CBC’s Journalistic Standards and Practices” without addressing specific concerns about the exclusion of opposing viewpoints.

The controversy highlights ongoing tensions in Canada’s approach to addressing the opioid crisis, with deep divisions between harm reduction advocates who support pharmaceutical alternatives to street drugs and critics who question the evidence, safety, and unintended consequences of such programs.